Health-Related Quality of Life Assessment in Patients with Myelodysplastic Syndromes: Evidence from Randomized Clinical Trials

Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis and blood cytopenia with a variable risk of progression to acute myeloid leukemia. The main goal of therapy for the large majority of patients is to improve health-related quality of life (HRQoL). Its rigorous assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Giesinger, Johannes M., La Nasa, Giorgio, Sparano, Francesco, Angermeyer, Matthias, Morelli, Emanuela, Mulas, Olga, Efficace, Fabio, Caocci, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2021
Materias:
Clinical Practice Epidemiology in Mental Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985474/
https://www.ncbi.nlm.nih.gov/pubmed/35444708
http://dx.doi.org/10.2174/1745017902117010307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985474/
https://www.ncbi.nlm.nih.gov/pubmed/35444708
http://dx.doi.org/10.2174/1745017902117010307

Ejemplares similares